Cleared Traditional

K832655 - ECOLYZER #200/COHB ANALYZER SYS

K832655 is the FDA 510(k) clearance for ECOLYZER #200/COHB ANALYZER SYS by Bd Becton Dickinson Vacutainer Systems Preanalytic. It is a Class 2 Anesthesiology device (product code CCJ) cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K832655 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
49d
Days
Class 2
Risk

K832655 is an FDA 510(k) clearance for the ECOLYZER #200/COHB ANALYZER SYS. Classified as Analyzer, Gas, Carbon-monoxide, Gaseous-phase (product code CCJ), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Washington, US). The FDA issued a Cleared decision on September 26, 1983 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1430 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

Submission Details

510(k) Number K832655 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 1983
Decision Date September 26, 1983
Days to Decision 49 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 140d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCJ Analyzer, Gas, Carbon-monoxide, Gaseous-phase

All 9
Devices cleared under the same product code (CCJ) and FDA review panel - the closest regulatory comparables to K832655.
ToxCO
K173238 · Bedfont Scientific, Ltd. · Apr 2019
CO Check Pro, CO Screen
K171129 · MD Diagnostics Limited · Mar 2018
CO TEST
K843845 · Erich Jaeger, Inc. · Oct 1984
ARGYLE DOUBLE SEAL CHEST DRAINAGE UNIT
K802891 · Sherwood Medical Co. · Dec 1980
DIFFUSION OPTION, OMNI-LAB
K781871 · Ohio Medical Products · Jan 1979
DIFFUSION SYSTEM, SINGLE-BREATH (47404A)
K760169 · Hewlett-Packard Co. · Jul 1976